Toth Financial Advisory Stake in Cvs Health (Call) (CVS) Trimmed by $6.81 Million as Market Valuation Declined; Quantbot Technologies LP Increased Its Bristol (BMY) Holding

April 25, 2018 - By Adrian Erickson

CVS Health Corporation (NYSE:CVS) Logo

Toth Financial Advisory Corp decreased its stake in Cvs Health Corp (Call) (CVS) by 99.78% based on its latest 2017Q4 regulatory filing with the SEC. Toth Financial Advisory Corp sold 90,786 shares as the company’s stock declined 17.45% with the market. The institutional investor held 200 shares of the medical and nursing services company at the end of 2017Q4, valued at $15,000, down from 90,986 at the end of the previous reported quarter. Toth Financial Advisory Corp who had been investing in Cvs Health Corp (Call) for a number of months, seems to be less bullish one the $67.95B market cap company. The stock increased 0.38% or $0.25 during the last trading session, reaching $66.85. About 1.01 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since April 25, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Quantbot Technologies Lp increased its stake in Bristol (BMY) by 236.01% based on its latest 2017Q4 regulatory filing with the SEC. Quantbot Technologies Lp bought 5,610 shares as the company’s stock rose 2.38% while stock markets declined. The hedge fund held 7,987 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $489,000, up from 2,377 at the end of the previous reported quarter. Quantbot Technologies Lp who had been investing in Bristol for a number of months, seems to be bullish on the $83.98B market cap company. The stock decreased 0.43% or $0.22 during the last trading session, reaching $51.36. About 1.71 million shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has risen 11.37% since April 25, 2017 and is uptrending. It has underperformed by 0.18% the S&P500.

Investors sentiment decreased to 0.72 in Q4 2017. Its down 0.16, from 0.88 in 2017Q3. It is negative, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Visionary Asset Management Inc stated it has 3,646 shares or 0.07% of all its holdings. Us Savings Bank De accumulated 0.33% or 1.47 million shares. Armistice Cap Ltd Llc holds 1.45% in CVS Health Corporation (NYSE:CVS) or 200,000 shares. Lodestar Invest Counsel Limited Liability Company Il, Illinois-based fund reported 55,444 shares. Hayek Kallen Mgmt invested in 14,335 shares. South State Corp owns 67,125 shares. Metropolitan Life Commerce New York, New York-based fund reported 157,105 shares. Nwq Invest Management Limited Liability Company invested 0.07% of its portfolio in CVS Health Corporation (NYSE:CVS). Riggs Asset Managment stated it has 570 shares. 56,338 were reported by Vigilant Cap Mgmt Limited Company. Shelton holds 0.09% or 19,046 shares in its portfolio. State Of Tennessee Treasury Department owns 438,610 shares for 0.14% of their portfolio. Exchange Cap Mgmt Inc reported 46,460 shares. Proffitt Goodson Incorporated has 0.44% invested in CVS Health Corporation (NYSE:CVS) for 14,562 shares. Tudor Inv Corporation Et Al invested 0.05% in CVS Health Corporation (NYSE:CVS).

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on May, 2 before the open. They expect $1.40 EPS, up 19.66% or $0.23 from last year’s $1.17 per share. CVS’s profit will be $1.42B for 11.94 P/E if the $1.40 EPS becomes a reality. After $1.92 actual EPS reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts -27.08% negative EPS growth.

Since February 16, 2018, it had 0 buys, and 1 insider sale for $1.42 million activity.

Toth Financial Advisory Corp, which manages about $319.42 million and $422.09M US Long portfolio, upped its stake in Select Sector Spdr Tr (XLI) by 10,372 shares to 120,874 shares, valued at $9.15 million in 2017Q4, according to the filing. It also increased its holding in Spdr S&P 500 Etf Tr (SPY) by 1,420 shares in the quarter, for a total of 4,304 shares, and has risen its stake in Spdr Series Trust (XRT).

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 76 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of CVS Health Corporation (NYSE:CVS) has “Outperform” rating given on Friday, August 28 by Oppenheimer. Robert W. Baird initiated the stock with “Outperform” rating in Friday, January 22 report. The stock of CVS Health Corporation (NYSE:CVS) earned “Hold” rating by Wolfe Research on Wednesday, August 16. Jefferies maintained CVS Health Corporation (NYSE:CVS) rating on Wednesday, August 16. Jefferies has “Hold” rating and $82.0 target. The company was maintained on Tuesday, December 26 by Tigress Financial. As per Thursday, February 2, the company rating was downgraded by Robert W. Baird. The firm earned “Buy” rating on Wednesday, November 9 by Mizuho. Needham maintained the stock with “Buy” rating in Tuesday, January 2 report. The firm earned “Neutral” rating on Monday, May 9 by Citigroup. Oppenheimer maintained CVS Health Corporation (NYSE:CVS) on Thursday, December 17 with “Outperform” rating.

Among 22 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 3 Sell and 12 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 84 analyst reports since July 28, 2015 according to SRatingsIntel. Credit Suisse maintained Bristol-Myers Squibb Company (NYSE:BMY) on Monday, May 9 with “Outperform” rating. As per Monday, October 23, the company rating was maintained by Leerink Swann. The company was maintained on Monday, August 14 by Cowen & Co. The firm has “Sell” rating by BMO Capital Markets given on Wednesday, August 16. On Friday, July 28 the stock rating was maintained by BMO Capital Markets with “Underperform”. The rating was upgraded by Piper Jaffray to “Underweight” on Monday, August 24. The stock has “Hold” rating by Jefferies on Monday, February 26. The rating was maintained by Jefferies on Tuesday, March 15 with “Hold”. The firm has “Hold” rating given on Friday, April 20 by Cowen & Co. UBS maintained Bristol-Myers Squibb Company (NYSE:BMY) on Friday, August 19 with “Buy” rating.

Since December 12, 2017, it had 1 buying transaction, and 1 insider sale for $85,985 activity. $249,187 worth of stock was bought by Samuels Theodore R. II on Friday, December 15.

Quantbot Technologies Lp, which manages about $581.51 million and $1.08 billion US Long portfolio, decreased its stake in Conagra Brands Inc (NYSE:CAG) by 132,332 shares to 21,682 shares, valued at $816,000 in 2017Q4, according to the filing. It also reduced its holding in Humana Inc (NYSE:HUM) by 22,039 shares in the quarter, leaving it with 5,762 shares, and cut its stake in Carlisle Cos Inc (NYSE:CSL).

Investors sentiment decreased to 0.94 in 2017 Q4. Its down 0.09, from 1.03 in 2017Q3. It dropped, as 72 investors sold BMY shares while 526 reduced holdings. 106 funds opened positions while 457 raised stakes. 1.11 billion shares or 0.48% more from 1.11 billion shares in 2017Q3 were reported. Profund Advsr Ltd Company holds 0.2% or 83,138 shares in its portfolio. Kornitzer Capital Mgmt Incorporated Ks reported 199,375 shares. Evergreen Management Ltd Liability Corporation accumulated 9,115 shares or 0.06% of the stock. Westend Advisors Ltd Liability invested in 3.9% or 689,109 shares. Fifth Third Bankshares stated it has 0.41% in Bristol-Myers Squibb Company (NYSE:BMY). Huntington Bankshares holds 0.53% or 541,149 shares. Gradient Investments Ltd Company holds 0.03% or 8,264 shares in its portfolio. Parkside Commercial Bank And Tru has invested 0.44% in Bristol-Myers Squibb Company (NYSE:BMY). Lee Danner Bass Inc has invested 0.28% in Bristol-Myers Squibb Company (NYSE:BMY). First City Cap Mngmt has 1.7% invested in Bristol-Myers Squibb Company (NYSE:BMY). Salzhauer Michael invested in 0.07% or 2,788 shares. Gulf Intll Commercial Bank (Uk) owns 519,055 shares or 0.4% of their US portfolio. Weatherly Asset Management Lp reported 4,243 shares or 0.06% of all its holdings. Lucas Cap Management invested 3.38% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Blair William Il owns 763,477 shares.

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: